BioCorRx Inc
Change company Symbol lookup
Select an option...
BICX BioCorRx Inc
SMSMY Sims Ltd
DHCAU DHC Acquisition Corp
BCH Banco de Chile
NLRCF Northern Lights Resources Corp
ABM ABM Industries Inc
LVOXW LiveVox Holding Equity Warrants Exp 18 June 2026 *W EXP 06/18/2026
TY- Tri-Continental Corp
BAC Bank of America Corp
KLXE KLX Energy Services Holdings Inc
Go

Company profile

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The Company's BioCorRx Recovery Program is a non-addictive, medication-assisted treatment (MAT) program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application. It is also engaged in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. Its products include BICX101 and BICX104. Its lead candidate, BICX101, is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. It is also developing an implantable naltrexone treatment, BICX104, a long-acting naltrexone implant that can last several months for the treatment of opioid dependence and alcohol use disorders. Its subsidiary is BioCorRx Pharmaceuticals, Inc.

Closing Price
$2.45
Day's Change
-0.05 (-2.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.45
Day's Low
2.43
Volume
(Light)
Volume:
457

10-day average volume:
2,743
457
  • Prev Close
    2.50
  • Today's Open
    2.43
  • Day's Range
    2.43-2.45
  • Avg Vol (10-day)
    2.7K
  • Last (time)
    3:20p ET 07/01/22
  • Last (size)
    170
  • 52-Wk Range
    2.21 - 7.50
    LowHigh
  • (11/10/21 - 05/05/22)
    10.86%
  • 157.8%
  • Market Cap
    17.0M
  • Shares Outstanding
    7.0M
  • -0.69
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 0.00
  • --

Latest News

June 30, 2022
9:00 am ET
Globe Newswire
June 17, 2022
9:00 am ET
Globe Newswire
May 31, 2022
9:00 am ET
Globe Newswire
May 19, 2022
8:00 am ET
Globe Newswire
May 17, 2022
8:30 am ET
Globe Newswire
April 27, 2022
9:01 am ET
Accesswire
9:01 am ET
Accesswire
9:01 am ET
Accesswire
9:01 am ET
Accesswire
9:01 am ET
Accesswire
8:30 am ET
Globe Newswire
April 26, 2022
8:30 am ET
Accesswire
April 19, 2022
9:02 am ET
Newsfile
April 11, 2022
8:30 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.